Trademark: 77486301
Word
ERKORMIS
Status
Dead
Status Code
710
Status Date
Friday, January 27, 2017
Serial Number
77486301
Registration Number
3805282
Registration Date
Tuesday, June 22, 2010
Mark Type
4000
Filing Date
Thursday, May 29, 2008
Published for Opposition
Tuesday, April 6, 2010
Cancellation Date
Friday, January 27, 2017

Trademark Owner History
AstraZeneca AB - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders

Trademark Events
Jan 27, 2017
Cancelled Sec. 8 (6-Yr)
Jun 22, 2010
Registered-Principal Register
Apr 6, 2010
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2010
Published For Opposition
Mar 4, 2010
Law Office Publication Review Completed
Mar 1, 2010
Approved For Pub - Principal Register
Feb 27, 2010
Teas/Email Correspondence Entered
Feb 26, 2010
Correspondence Received In Law Office
Feb 26, 2010
Teas Response To Suspension Inquiry Received
Aug 27, 2009
Notification Of Inquiry As To Suspension E-Mailed
Aug 27, 2009
Inquiry To Suspension E-Mailed
Aug 27, 2009
Suspension Inquiry Written
Aug 27, 2009
Assigned To Examiner
Aug 20, 2009
Lie Checked Susp - To Atty For Action
Feb 20, 2009
Notification Of Letter Of Suspension E-Mailed
Feb 20, 2009
Letter Of Suspension E-Mailed
Feb 20, 2009
Suspension Letter Written
Feb 19, 2009
Examiner's Amendment Entered
Feb 19, 2009
Assigned To Lie
Feb 19, 2009
Notification Of Examiners Amendment E-Mailed
Feb 19, 2009
Examiners Amendment E-Mailed
Feb 19, 2009
Examiners Amendment -Written
Sep 11, 2008
Notification Of Non-Final Action E-Mailed
Sep 11, 2008
Non-Final Action E-Mailed
Sep 11, 2008
Non-Final Action Written
Sep 10, 2008
Assigned To Examiner
Jun 2, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24